Adaptemy
PrivateLast Round
Grant
Apr 12, 2024
Total Funding Raised
$3.97M
Company Overview
Adaptemy is an educational technology company that provides an AI-powered adaptive learning platform and consultancy services to educational publishers and institutions.
Sector
Enterprise Software
Verticals
Vertical SaaS, NLP & Conversational AI, Personalization, Digital Publishing, API Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptemy Comparables
Compare Adaptemy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cambridge University Press & Assessment | 77% | |
| Pearson plc | 74% | |
| Rise Up | 71% | |
Adaptemy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 12, 2024 | ||||
| Seed | Jan 23, 2017 |
Adaptemy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enterprise Ireland | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Grew 36% QoQ from 11 to 15 employees.
- Apr 12, 2024
$460K raised from Horizon Europe
Adaptemy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adaptemy's valuation, stock price, and market status.